Advanced search
Publication Cover
Current Medical Research and Opinion Volume 27, 2011 - Issue 6
Submit an article Journal homepage
255
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Use of hypomethylating agents and associated care in patients with myelodysplastic syndromes: a claims database study

Hind T. HatoumHind T. Hatoum & Company and Pharmacy Administration, The University of Illinois at Chicago, IL, USACorrespondence[email protected]
,
Swu-Jane LinPharmacy Administration, The University of Illinois at Chicago and Hind T. Hatoum & Company, Chicago IL, USA
,
Deborah BuchnerEisai Inc., Woodcliff Lake, NJ, USA
&
Edward KimFormer employee of Eisai Inc., Woodcliff Lake, NY, USA
Pages 1255-1262 | Accepted 25 Mar 2011, Published online: 10 May 2011

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Eytan M. Stein, Gaetano Bonifacio, Dominick Latremouille-Viau, Sherry Shi, Annie Guerin, Eric Q. Wu, Islam Sadek & Xiting Cao. (2021) Treatment patterns and outcomes in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysis. Leukemia & Lymphoma 62:6, pages 1411-1421.
Read now

Articles from other publishers (2)

Christopher R. Cogle, Sandra E. Kurtin, Tanya G. K. Bentley, Michael S. Broder, Eunice Chang, Scott Megaffin, Steven Fruchtman, Michael E. Petrone & Sudipto Mukherjee. (2017) The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail. The Oncologist 22:4, pages 379-385.
Crossref
Katarzyna Lamparska, Jarrod Clark, Gail Babilonia, Victoria Bedell, Wesley Yip & Steven S. Smith. (2012) 2′-Deoxyriboguanylurea, the primary breakdown product of 5-aza-2′-deoxyribocytidine, is a mutagen, an epimutagen, an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sites. Nucleic Acids Research 40:19, pages 9788-9801.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.